KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 97 filers reported holding KURA ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262 | -99.9% | 30,000 | +20.5% | 0.00% | 0.0% |
| Q3 2022 | $327,000 | -27.0% | 24,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $448,000 | +11.7% | 24,900 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $401,000 | +22.3% | 24,900 | +10.2% | 0.00% | 0.0% |
| Q4 2021 | $328,000 | -20.0% | 22,600 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $410,000 | -12.8% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $470,000 | -73.6% | 22,000 | -67.2% | 0.00% | -83.3% |
| Q1 2021 | $1,779,000 | -21.2% | 67,000 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $2,258,000 | -45.3% | 67,000 | -50.9% | 0.01% | -55.6% |
| Q3 2020 | $4,127,000 | +963.7% | 136,400 | +595.9% | 0.02% | +800.0% |
| Q2 2019 | $388,000 | +65.1% | 19,600 | +63.3% | 0.00% | +100.0% |
| Q1 2019 | $235,000 | +85.0% | 12,000 | +22.4% | 0.00% | 0.0% |
| Q4 2018 | $127,000 | -46.0% | 9,800 | -18.3% | 0.00% | 0.0% |
| Q3 2018 | $235,000 | +10.3% | 12,000 | -2.4% | 0.00% | 0.0% |
| Q2 2018 | $213,000 | -5.8% | 12,300 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $226,000 | – | 12,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |